Hidetaka Yamamoto

About Hidetaka Yamamoto

Hidetaka Yamamoto, With an exceptional h-index of 48 and a recent h-index of 31 (since 2020), a distinguished researcher at Kyushu University, specializes in the field of Pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma

PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer

Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma

Comprehensive molecular profiling broadens treatment options for breast cancer patients

Benign mesenteric lipomatous tumor in a child: a case report and literature review

Chronic inflammatory changes and oxidative stress in the background of “pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm”

Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas

Hidetaka Yamamoto Information

University

Position

___

Citations(all)

8019

Citations(since 2020)

3383

Cited By

5879

hIndex(all)

48

hIndex(since 2020)

31

i10Index(all)

152

i10Index(since 2020)

118

Email

University Profile Page

Google Scholar

Hidetaka Yamamoto Skills & Research Interests

Pathology

Top articles of Hidetaka Yamamoto

Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma

Anticancer Research

2021/1

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Takashi Nakagawa
Takashi Nakagawa

H-Index: 26

PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I

Oncology reports

2021/1

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer

Oncoimmunology

2020/1/1

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma

Human pathology

2020/12/7

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Takafumi Nakano
Takafumi Nakano

H-Index: 6

Comprehensive molecular profiling broadens treatment options for breast cancer patients

Cancer Medicine

2020/12/4

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Eiji Oki
Eiji Oki

H-Index: 21

Masaki Mori
Masaki Mori

H-Index: 1

Benign mesenteric lipomatous tumor in a child: a case report and literature review

2020/12

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Yoshiaki Tanaka
Yoshiaki Tanaka

H-Index: 44

Chronic inflammatory changes and oxidative stress in the background of “pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm”

Virchows Archiv

2020/12

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas

Human Pathology

2020/12/1

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI

European Radiology

2020/12

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Efficacy of endoscopic ultrasound with artificial intelligence for the diagnosis of gastrointestinal stromal tumors

Journal of gastroenterology

2020/12

Eikichi Ihara
Eikichi Ihara

H-Index: 16

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor

Journal of Cancer Research and Clinical Oncology

2020/11/21

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Prognostic impact of CRTC1/3‐MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study

Cancer science

2020/11

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Frequent MN1 Gene Mutations in Malignant Peripheral Nerve Sheath Tumor

Anticancer research

2020/11/1

PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions

Journal of cancer research and clinical oncology

2020/10

Yoshihiro Ito
Yoshihiro Ito

H-Index: 27

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan

International journal of clinical oncology

2020/10

Ken-Ichi Nibu
Ken-Ichi Nibu

H-Index: 25

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Clinicopathologic significance of EGFR mutation and HPV infection in sinonasal squamous cell carcinoma

The American Journal of Surgical Pathology

2020/8/28

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Takashi Nakagawa
Takashi Nakagawa

H-Index: 26

Amide proton transfer (APT) imaging of parotid tumors: Differentiation of malignant and benign tumors

European Journal of Radiology

2020/8/1

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Genetic landscape of external auditory canal squamous cell carcinoma

Cancer science

2020/8

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Takashi Nakagawa
Takashi Nakagawa

H-Index: 26

Central pathology review of salivary gland adenoid cystic carcinoma

2020/8

Hidetaka Yamamoto
Hidetaka Yamamoto

H-Index: 26

Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review

2020/6/2

See List of Professors in Hidetaka Yamamoto University(Kyushu University)